{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T12:49:00Z","timestamp":1648730940017},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1007\/s00105-012-2421-0","type":"journal-article","created":{"date-parts":[[2012,9,6]],"date-time":"2012-09-06T17:04:37Z","timestamp":1346951077000},"page":"727-738","source":"Crossref","is-referenced-by-count":0,"title":["Intensivpflichtige Hauterkrankungen"],"prefix":"10.1007","volume":"63","author":[{"given":"C.","family":"Marks","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Marks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,9,8]]},"reference":[{"key":"2421_CR1","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1001\/archderm.138.8.1019","volume":"138","author":"Auquier-Dunant","year":"2002","unstructured":"Auquier-Dunant A, Mockenhaupt M, Naldi L et al (2002) Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study. Arch Dermatol 138:1019\u20131024","journal-title":"Arch Dermatol"},{"key":"2421_CR2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2500\/aap.2009.30.3188","volume":"30","author":"Banerji","year":"2009","unstructured":"Banerji A, Sheffer AL (2009) The spectrum of chronic angioedema. Allergy Asthma Proc 30:11\u201316","journal-title":"Allergy Asthma Proc"},{"key":"2421_CR3","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1046\/j.1523-1747.2000.00061.x","volume":"115","author":"Bastuji-Garin","year":"2000","unstructured":"Bastuji-Garin S, Fouchard N, Bertocchi M et al (2000) SCORTEN: a severity-of-illness score for toxic epidermal necrolysis. J Invest Dermatol 115:149\u2013153","journal-title":"J Invest Dermatol"},{"key":"2421_CR4","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1001\/archderm.1993.01680220104023","volume":"129","author":"Bastuji-Garin","year":"1993","unstructured":"Bastuji-Garin S, Rzany B, Stern RS et al (1993) Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol 129:92\u201396","journal-title":"Arch Dermatol"},{"key":"2421_CR5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ijantimicag.2009.09.013","volume":"35","author":"Beibei","year":"2010","unstructured":"Beibei L, Yun C, Mengli C et al (2010) Linezolid versus vancomycin for the treatment of gram-positive bacterial infections: meta-analysis of randomised controlled trials. Int J Antimicrob Agents 35:3\u201312","journal-title":"Int J Antimicrob Agents"},{"key":"2421_CR6","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0140-6736(00)02483-1","volume":"356","author":"Bork","year":"2000","unstructured":"Bork K, Barnstedt SE, Koch P, Traupe H (2000) Hereditary angioedema with normal C1-inhibitor activity in women. Lancet 356:213\u2013217","journal-title":"Lancet"},{"key":"2421_CR7","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1086\/509899","volume":"79","author":"Cichon","year":"2006","unstructured":"Cichon S, Martin L, Hennies HC et al (2006) Increased activity of coagulation factor XII (Hageman factor) causes hereditary angioedema type III. Am J Hum Genet 79:1098\u20131104","journal-title":"Am J Hum Genet"},{"key":"2421_CR8","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1097\/00002030-200109280-00014","volume":"15","author":"Fagot","year":"2001","unstructured":"Fagot JP, Mockenhaupt M, Bouwes-Bavinck JN et al (2001) Nevirapine and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. Aids 15:1843\u20131848","journal-title":"Aids"},{"key":"2421_CR9","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.2165\/00003495-200565150-00002","volume":"65","author":"Faye","year":"2005","unstructured":"Faye O, Roujeau JC (2005) Treatment of epidermal necrolysis with high-dose intravenous immunoglobulins (IV Ig): clinical experience to date. Drugs 65:2085\u20132090","journal-title":"Drugs"},{"key":"2421_CR10","doi-asserted-by":"crossref","first-page":"5","DOI":"10.5070\/D397D8T291","volume":"8","author":"Ghislain","year":"2002","unstructured":"Ghislain PD, Roujeau JC (2002) Treatment of severe drug reactions: Stevens-Johnson syndrome, toxic epidermal necrolysis and hypersensitivity syndrome. Dermatol Online J 8:5","journal-title":"Dermatol Online J"},{"key":"2421_CR11","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jaad.2007.08.036","volume":"58","author":"Halevy","year":"2008","unstructured":"Halevy S, Ghislain PD, Mockenhaupt M et al (2008) Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel. J Am Acad Dermatol 58:25\u201332","journal-title":"J Am Acad Dermatol"},{"key":"2421_CR12","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s00105-005-1089-0","volume":"57","author":"Kahle","year":"2006","unstructured":"Kahle B (2006) Vascular emergencies in dermatology. Hautarzt 57:202\u2013206","journal-title":"Hautarzt"},{"key":"2421_CR13","doi-asserted-by":"crossref","first-page":"144","DOI":"10.2340\/00015555-0214","volume":"87","author":"Kardaun","year":"2007","unstructured":"Kardaun SH, Jonkman MF (2007) Dexamethasone pulse therapy for Stevens-Johnson syndrome\/toxic epidermal necrolysis. Acta Derm Venereol 87:144\u2013148","journal-title":"Acta Derm Venereol"},{"key":"2421_CR14","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/MOP.0b013e3283483efd","volume":"23","author":"Kress","year":"2011","unstructured":"Kress DW (2011) Pediatric dermatology emergencies. Curr Opin Pediatr 23:403\u2013406","journal-title":"Curr Opin Pediatr"},{"key":"2421_CR15","doi-asserted-by":"crossref","unstructured":"Kroshinsky D, Alloo A, Rothschild B et al (2012) Necrotizing Sweet syndrome: a new variant of neutrophilic dermatosis mimicking necrotizing fasciitis. J Am Acad Dermatol [Epub ahead of print]","DOI":"10.1016\/j.jaad.2012.02.024"},{"key":"2421_CR16","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1097\/TA.0b013e318232a6b3","volume":"72","author":"Lancerotto","year":"2012","unstructured":"Lancerotto L, Tocco I, Salmaso R et al (2012) Necrotizing fasciitis: classification, diagnosis, and management. J Trauma Acute Care Surg 72:560\u2013566","journal-title":"J Trauma Acute Care Surg"},{"key":"2421_CR17","doi-asserted-by":"crossref","first-page":"e297","DOI":"10.1542\/peds.2008-1923","volume":"123","author":"Levi","year":"2009","unstructured":"Levi N, Bastuji-Garin S, Mockenhaupt M et al (2009) Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis. Pediatrics 123:e297\u2013304","journal-title":"Pediatrics"},{"key":"2421_CR18","doi-asserted-by":"crossref","first-page":"654","DOI":"10.12968\/hmed.2006.67.12.22439","volume":"Med","author":"Longhurst","year":"2006","unstructured":"Longhurst HJ, Bork K (2006) Hereditary angioedema: causes, manifestations and treatment. Br J Hosp Med (Lond) 67:654\u2013657","journal-title":"Br J Hosp"},{"key":"2421_CR19","first-page":"663","volume":"8","author":"Maurer","year":"2010","unstructured":"Maurer M, Magerl M (2010) Hereditary angioedema: an update on available therapeutic options. J Dtsch Dermatol Ges 8:663\u2013672","journal-title":"J Dtsch Dermatol Ges"},{"key":"2421_CR20","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1586\/eci.11.66","volume":"7","author":"Mockenhaupt","year":"2011","unstructured":"Mockenhaupt M (2011) The current understanding of Stevens-Johnson syndrome and toxic epidermal necrolysis. Expert Rev Clin Immunol 7:803\u2013813 (quiz 814\u2013805)","journal-title":"Expert Rev Clin Immunol"},{"key":"2421_CR21","first-page":"142","volume":"7","author":"Mockenhaupt","year":"2009","unstructured":"Mockenhaupt M (2009) Severe drug-induced skin reactions: clinical pattern, diagnostics and therapy. J Dtsch Dermatol Ges 7:142\u2013160 (quiz 161\u2013142)","journal-title":"J Dtsch Dermatol Ges"},{"key":"2421_CR22","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/j.0022-202X.2005.23642.x","volume":"124","author":"Mockenhaupt","year":"2005","unstructured":"Mockenhaupt M, Idzko M, Grosber M et al (2005) Epidemiology of staphylococcal scalded skin syndrome in Germany. J Invest Dermatol 124:700\u2013703","journal-title":"J Invest Dermatol"},{"key":"2421_CR23","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/sj.jid.5701033","volume":"128","author":"Mockenhaupt","year":"2008","unstructured":"Mockenhaupt M, Viboud C, Dunant A et al (2008) Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study. J Invest Dermatol 128:35\u201344","journal-title":"J Invest Dermatol"},{"key":"2421_CR24","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2165\/00128071-200304030-00003","volume":"4","author":"Patel","year":"2003","unstructured":"Patel GK, Finlay AY (2003) Staphylococcal scalded skin syndrome: diagnosis and management. Am J Clin Dermatol 4:165\u2013175","journal-title":"Am J Clin Dermatol"},{"key":"2421_CR25","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.clindermatol.2004.06.001","volume":"23","author":"Pitambe","year":"2005","unstructured":"Pitambe HV, Schulz EJ (2005) Life-threatening dermatoses due to metabolic and endocrine disorders. Clin Dermatol 23:258\u2013266","journal-title":"Clin Dermatol"},{"key":"2421_CR26","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/clpt.2009.252","volume":"88","author":"Sassolas","year":"2010","unstructured":"Sassolas B, Haddad C, Mockenhaupt M et al (2010) ALDEN, an algorithm for assessment of drug causality in Stevens-Johnson Syndrome and toxic epidermal necrolysis: comparison with case-control analysis. Clin Pharmacol Ther 88:60\u201368","journal-title":"Clin Pharmacol Ther"},{"key":"2421_CR27","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jaad.2007.08.039","volume":"58","author":"Schneck","year":"2008","unstructured":"Schneck J, Fagot JP, Sekula P et al (2008) Effects of treatments on the mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis: a retrospective study on patients included in the prospective EuroSCAR Study. J Am Acad Dermatol 58:33\u201340","journal-title":"J Am Acad Dermatol"},{"key":"2421_CR28","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1186\/cc2937","volume":"9","author":"Semple","year":"2005","unstructured":"Semple D, Keogh J, Forni L, Venn R (2005) Clinical review: vasculitis on the intensive care unit \u2013 part 2: treatment and prognosis. Crit Care 9:193\u2013197","journal-title":"Crit Care"},{"key":"2421_CR29","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00105-012-2341-z","volume":"63","author":"Stander","year":"2012","unstructured":"Stander HF (2012) Medical emergencies in daily dermatological practice. Hautarzt 63:329\u2013340","journal-title":"Hautarzt"},{"key":"2421_CR30","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.clindermatol.2004.06.011","volume":"23","author":"Stone","year":"2005","unstructured":"Stone SP, Buescher LS (2005) Life-threatening paraneoplastic cutaneous syndromes. Clin Dermatol 23:301\u2013306","journal-title":"Clin Dermatol"},{"key":"2421_CR31","first-page":"773","volume":"82","author":"Usatine","year":"2010","unstructured":"Usatine RP, Sandy N (2010) Dermatologic emergencies. Am Fam Physician 82:773\u2013780","journal-title":"Am Fam Physician"},{"key":"2421_CR32","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1111\/j.1365-2133.2010.09863.x","volume":"163","author":"Valeyrie-Allanore","year":"2010","unstructured":"Valeyrie-Allanore L, Wolkenstein P, Brochard L et al (2010) Open trial of ciclosporin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis. Br J Dermatol 163:847\u2013853","journal-title":"Br J Dermatol"},{"key":"2421_CR33","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1126\/science.282.5388.490","volume":"282","author":"Viard","year":"1998","unstructured":"Viard I, Wehrli P, Bullani R et al (1998) Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science 282:490\u2013493 (New York, NY)","journal-title":"Science"},{"key":"2421_CR34","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/S0140-6736(98)02197-7","volume":"352","author":"Wolkenstein","year":"1998","unstructured":"Wolkenstein P, Latarjet J, Roujeau JC et al (1998) Randomised comparison of thalidomide versus placebo in toxic epidermal necrolysis. Lancet 352:1586\u20131589","journal-title":"Lancet"},{"key":"2421_CR35","first-page":"138","volume":"12","author":"W\u00fcthrich","year":"2012","unstructured":"W\u00fcthrich B (2012) Angio\u00f6deme, selten allergisch bedingt. 1. Teil: Klassifikation, Pathophysiologie, Diagnostik. Schweiz Med Forum 12:138\u2013143","journal-title":"Schweiz Med Forum"},{"key":"2421_CR36","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1001\/archderm.143.6.711","volume":"143","author":"Ziemer","year":"2007","unstructured":"Ziemer M, Wiesend CL, Vetter R et al (2007) Cutaneous adverse reactions to valdecoxib distinct from Stevens-Johnson syndrome and toxic epidermal necrolysis. Arch Dermatol 143:711\u2013716","journal-title":"Arch Dermatol"},{"key":"2421_CR37","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1111\/j.1398-9995.2009.02179.x","volume":"64","author":"Zuberbier","year":"2009","unstructured":"Zuberbier T, Asero R, Bindslev-Jensen C et al (2009) EAACI\/GA(2)LEN\/EDF\/WAO guideline: definition, classification and diagnosis of urticaria. Allergy 64:1417\u20131426","journal-title":"Allergy"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-012-2421-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00105-012-2421-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-012-2421-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T11:10:39Z","timestamp":1643368239000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00105-012-2421-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":37,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["2421"],"URL":"https:\/\/doi.org\/10.1007\/s00105-012-2421-0","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}